18Sep
Government Continues to Closely Scrutinize Pharmaceutical Marketing Practices
On September 4, 2019 the Department of Justice (DOJ) announced a $15.4 million settlement with pharmaceutical company Mallinckrodt ARD LLC (Mallinckrodt) to resolve alleged violations of the Anti-Kickback Statute (AKS) in two whistleblower suits...
By:
Robinson+Cole Health Law Diagnosis
Related
Economic volatility, political unrest and fierce competition are all seen as major challenges to the...
Read More >
Companies with a history of consistent revenue growth and adjusted EBITDA make attractive acquisitio...
Read More >
In today’s edition of Daily Compliance News: What happens when you have an innovation and no one t...
Read More >
Megamergers that deprive the American consumer of competition are illegal. But the urge to merge is...
Read More >
The beauty of the retirement plan business is that it isn't static, it's constantly changing. One of...
Read More >
Traditional companies are responding to the challenge of digital disruption by partnering with techn...
Read More >